deltatrials
Completed OBSERVATIONAL NCT02945904

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism (MATCH)

Sponsor: Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE

Interventions adrenalectomy
Updated 16 times since 2017 Last updated: Mar 7, 2025 Started: Dec 1, 2016 Primary completion: Aug 31, 2021 Completion: Aug 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hyperaldosteronism and Primary Aldosteronism and is currently completed. Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE leads this study, which shows 16 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Mar 2018 · 7 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Apr 2025 — Sep 2025 [monthly]

    Completed

  3. Sep 2024 — Apr 2025 [monthly]

    Completed

  4. Aug 2024 — Sep 2024 [monthly]

    Completed

    Status: UnknownCompleted

  5. Jul 2024 — Aug 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

Show 11 earlier versions
  1. Mar 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

  2. Dec 2021 — Mar 2022 [monthly]

    Recruiting

  3. Feb 2021 — Dec 2021 [monthly]

    Recruiting

    Status: Unknown StatusRecruiting

  4. Jan 2021 — Feb 2021 [monthly]

    Unknown Status

  5. Nov 2020 — Jan 2021 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

  6. Jun 2018 — Nov 2020 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  9. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  10. Aug 2017 — Mar 2018 [monthly]

    Not Yet Recruiting NA

  11. Jan 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE
  • National Institute for Health Research, United Kingdom
  • Queen Mary University of London
  • Robertson Centre for Biostatistics University of Glasgow Glasgow G12 8QQ
  • WBIC), Cambridge. University of Cambridge Addenbrookes Hospital, Cambridge CB2 2QQ
Data source: Queen Mary University of London

For direct contact, visit the study record on ClinicalTrials.gov .